Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 2000 2023-07-14 01:42:02 |
2 format change + 2 word(s) 2002 2023-07-14 03:39:44 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Tsigkas, G.; Papanikolaou, A.; Apostolos, A.; Kramvis, A.; Timpilis, F.; Latta, A.; Papafaklis, M.I.; Aminian, A.; Davlouros, P. Radial Artery Occlusion. Encyclopedia. Available online: https://encyclopedia.pub/entry/46792 (accessed on 04 July 2024).
Tsigkas G, Papanikolaou A, Apostolos A, Kramvis A, Timpilis F, Latta A, et al. Radial Artery Occlusion. Encyclopedia. Available at: https://encyclopedia.pub/entry/46792. Accessed July 04, 2024.
Tsigkas, Grigorios, Amalia Papanikolaou, Anastasios Apostolos, Angelos Kramvis, Filippos Timpilis, Anastasia Latta, Michail I. Papafaklis, Adel Aminian, Periklis Davlouros. "Radial Artery Occlusion" Encyclopedia, https://encyclopedia.pub/entry/46792 (accessed July 04, 2024).
Tsigkas, G., Papanikolaou, A., Apostolos, A., Kramvis, A., Timpilis, F., Latta, A., Papafaklis, M.I., Aminian, A., & Davlouros, P. (2023, July 14). Radial Artery Occlusion. In Encyclopedia. https://encyclopedia.pub/entry/46792
Tsigkas, Grigorios, et al. "Radial Artery Occlusion." Encyclopedia. Web. 14 July, 2023.
Radial Artery Occlusion
Edit

The thrombotic occlusion of the radial artery has emerged as the most common complication of transradial coronary access, impeding its use in future interventions, and in the creation of arteriovenous fistulae for hemodialysis patients, or as a graft for coronary artery bypass grafting. In this entry, the researchers delve into the anatomy of the radial artery, the pathophysiology, and diagnosis of radial artery occlusion, the identification of potential risk factors, and finally prevention and treatment strategies. It is acknowledged that distal transradial access provides an effective alternative for coronary angiography and catheterization, with a reduced incidence of radial artery occlusion.

RAO radial artery occlusion dTRA

1. Radial Artery Occlusion (RAO) Pathophysiology

RAO may arise typically due to endothelial injury and decreased blood flow during the insertion of sheaths and catheters at the catheterization site, as well as during manipulations throughout the procedure. More specifically, during sheath insertion, the intima of the vessel may be damaged, leading to local exposure of collagen fibers and tissue factors, while blood flow is halted in the radial artery. Consequently, the coagulation cascade is triggered, causing platelets and fibrin to aggregate at the site of vascular injury, leading to thrombus formation and local thrombosis of the radial artery.
However, arterial occlusion following percutaneous coronary procedures could be a result of compression phenomena, due to local induction by the catheterization process edema or hematoma [1][2].
The dual blood supply to the hand confers a quiescent character of RAO in most patients, which results in the majority of cases going undetected. Symptoms indicating RAO, such as pain at the site of the thrombosis, paresthesia, and decreased limb function, are only present in a minority of cases, accounting for approximately 0.2% of patients. Hand ischemia due to RAO occurs exclusively in individuals with insufficient collateral circulation, mostly on account of anatomic variations [3].

2. RAO Diagnosis

Doppler ultrasonography is widely considered to be the gold standard method for assessing radial artery patency following transradial access, owing to its ability to provide both hemodynamic information and anatomical details of the vessel. Nevertheless, current research has investigated alternative methods, taking into account factors such as cost, time, and availability, in order to assess their efficacy in detecting RAO.
Digital plethysmography, using a modified reverse Barbeau’s test, is a more affordable and less time-consuming method compared to a Doppler ultrasound. Plethysmography sampling involves placing a digital sensor on the index finger or thumb to evaluate the patency of the radial artery after transradial access. This is achieved by compressing both the radial and ulnar arteries, causing the oximetry signal to be lost. The release of the radial artery leads to the recovery of the signal, indicating radial artery patency.
While the modified reverse Barbeau’s test, similar to the modified Allen’s test, has been, until now, used as a method to clinically assess the adequacy of the ulnar artery’s collateral flow before the radial artery’s catheterization, in recent randomized controlled trials (RCTs), the effectiveness of this method has been compared to that of Doppler ultrasonography (USG) in detecting RAO. Important findings indicate that there is no significant difference in the efficacy of the two methods [3][4][5].
Laser perfusion imaging (LPI) has recently emerged as a novel and operator-independent diagnostic tool to evaluate radial artery perfusion following transradial catheterization. This diagnostic method involves capturing a color-coded perfusion image of the hand palm in a state of rest. Subsequently, a second image is captured after occluding the ulnar artery with pressure. The diagnosis of RAO is determined by calculating the radial perfusion index (RPI), which is the ratio between the basal radial perfusion and the value measured under ulnar occlusion. Notably, LPI is particularly useful for patients with anatomical variations presenting difficulties during catheterization. Furthermore, the lack of direct skin contact during LPI eliminates any pain or infection associated with probe contact. Additionally, the operator-independent nature of LPI makes it more objective and cost-effective than other methods. Although LPI is a relatively new technology, its potential as a reliable and practical diagnostic tool for RAO warrants further investigation [6].

3. RAO Inducing Factors

Many factors contribute mainly to thrombus formation and, consequently, predisposition to RAO. These can be divided into modifiable and non-modifiable, or patient-related and procedurally-induced risk factors.
Several patient-related risk factors have been identified for RAO, including younger age, female sex, low body mass index, diabetes mellitus, dyslipidemia, peripheral artery disease, multiple vessel coronary artery disease, reduced renal function, and previous radial artery cannulation. Among these factors, cardiovascular risk factors could be modified over the years through lifestyle changes and pharmacological interventions, whereas previous radial artery cannulation is an unmodifiable risk factor that does not constitute a generic characteristic. Unfortunately, repeated radial cannulation leads to intimal hyperplasia and intima-media thickening, resulting in reduced lumen diameter [7].
On the other hand, hypertension has been proposed to exert a protective effect against RAO, by inducing a hyperdynamic state within the arterial lumen, leading to gradual reopening of the occluded portion of the artery. Consequently, unlike other known risk factors for atherosclerosis, hypertension appears to have a unique effect in this regard [8].
On top of that, there are some procedural RAO inducing factors, which could be mitigated by the operator’s experience and focus during the operation on minimizing traumatic injury to the radial artery. These risk factors include a sheath-to-artery ratio greater than 1, repeated unsuccessful attempts at a radial artery puncture, a radial artery spasm, the use of multiple catheters, periprocedural anticoagulation, occlusive hemostasis and, finally, longer periprocedural and hemostasis times.
Post-procedural pain at the cannulation site and hematoma formation are both considered to be contributing factors to thrombotic radial artery occlusion. Paradoxically, the formation of a hematoma after removal of the hemostatic device is thought to increase the risk of thrombus formation, as the operator may need to manipulate the access site in order to minimize its extent [7][9].
The minimization of the modifiable risk factors could be a helpful tool for reducing rates of post-procedural radial artery thrombosis [10].

4. RAO Preventive Strategies

i.
Repeated radial punctures and Doppler evaluation
A recurrent endothelial injury from repeated punctures can lead to damage of the vessel wall and early thrombus formation. Thus, the pre-interventional visualization of the radial artery in both limbs using Doppler ultrasonography is suggested in order to assess the radial artery’s characteristics. More specifically, it is useful for the selection of an artery with a wider diameter, and the illustration of the caliber and depth of the vessel. As a result, the cannulation of the artery is more easily achieved, and the need for repeated puncture attempts is reduced [11][12]. Additionally, this imaging modality can aid in selecting an appropriate sheath size to reduce the sheath-to-artery mismatch, thereby minimizing the risk of RAO [13].
ii.
Sheath Size
Minimizing the size of equipment used in coronary interventions is crucial in reducing the incidence of RAO. A sheath-to-artery diameter ratio mismatch can result in an injury to the radial artery wall, endothelial dysfunction, blood flow disturbance, and chronic vascular remodeling. Studies have shown that a sheath-to-artery diameter ratio of less than 1 is associated with a lower risk of RAO.
iii.
Vasodilators
It is argued that the subcutaneous injection of nitroglycerin at the radial artery puncture site offers significant vasodilation of the radial artery. This approach facilitates the cannulation. As a result, the number of punctures and the incidence of radial artery spasm are reduced [14][15][16].
Even so, its impact on radial artery occlusion is controversial. Until recently, the pre-hemostasis injection of 500 μg nitroglycerin seemed to reduce the rate of RAO due to the influence of nitrous oxide on the intimal inflammation and hyperplasia of the radial artery [14][17]. However, a recently published study came to overthrow this argument by showing that nitroglycerin had no impact on the incidence of RAO regardless of its administration timing, whether upon sheath insertion or before its removal [13].
iv.
Anticoagulation
Adequate anticoagulation is an important aspect within the multifactorial preventive strategy for the prevention of RAO, as its pathogenesis is majorly associated with thrombus formation. A bolus dose of 50 IU/Kg or 5000 IU unfractionated heparin (UFH) was, until recently, recommended to be efficient in RAO prevention, regardless of the delivery route, whether intravenously or via the arterial sheath [18]. For this reason, the effect of the standard heparinization dose on RAO has been compared with higher or lower doses in multiple RCTs.
v.
Hemostasis Methods
The procedure between sheath removal and the removal of the hemostatic device is defined as hemostasis. Occlusive hemostasis, hemostatic devices, and hemostasis duration play a major role in thrombus formation, due to the initiation of decreased blood flow.
Evidence-based contemporary protocols have shown that not only has the option for different hemostatic devices little effect on radial artery thrombosis, but also that the presence of non-occlusive hemostasis appears to be a much more important factor [19][20][21].

5. RAO Treatment

Although RAO is suggested to be treated only in symptomatic patients, a patent radial artery is of great importance, because otherwise it could not be used for coronary artery catheterization in the future, for grafting purposes during coronary artery bypass surgeries, and for arteriovenous fistula formation in case of hemodialysis. In addition, prior RAO is a contraindication for the ipsilateral transulnar approach, which further limits the operator’s options in the catheterization laboratory, especially when time is of the essence.
If RAO is diagnosed before discharge, the ipsilateral compression of the ulnar artery for an hour may be an effective technique in order to regain the artery’s patency. This method is associated with an increase in radial blood flow, thereby initiating the release of vasodilator mediators [22].
Apart from this, for patients with persistent RAO, the therapeutic options include either medical treatment with anticoagulation agents for 1–3 months, or percutaneous retrograde revascularization [23][24][25][26].
In most cases, the anticoagulation therapy of choice for people suffering from symptomatic RAO is a body-weight-adjusted dosage of low-molecular-weight-heparin (LMWH) agents. More specifically, in the majority of patients it is either enoxaparin 10 mg per 10 kg body weight, subcutaneously (s.c.) twice daily administered or, for people weighting between 50–100 kg, s.c. fondaparinux 7.5 mg is administered once daily. Prophylactic doses of 40 mg or 2.5 mg once daily of enoxaparin or fondaparinux, respectively are only used in patients, who are simultaneously treated with dual antiplatelet therapy due to coronary artery disease [27][28].
In addition to that, the use of novel oral anticoagulation agents and, especially, apixaban has been recently proposed as an alternative and more convenient option to subcutaneous therapy. Nevertheless, its benefit should be further investigated, because the current literature is limited [29].
The restoration of the blood flow of the radial artery can be also interventionally achieved from a proximal part of the forearm, where the pulse is still palpated. In patients in whom the insertion of a 5F sheath and a guide wire is successful, a small channel could be opened and, therefore, depicted with the introduction of contrast medium. More severe and total occlusive lesions could be over-passed with the help of a J-typed guidewire and, when this method fails, the thrombi from the radial artery may be aspirated via a balloon dilation and drilling technique [23].
Of note, retrograde recanalization can be also pursued in our era through dTRA. The most popular method that has been proposed lately is the aspiration of the thrombus directly through the inducer sheath, or through an aspiration catheter. Furthermore, promising results have been retrieved by the conduct of balloon angioplasty through the dTRA, or the transcatheter administration of thrombolytic therapy [30][31].
These techniques are considered safe for major events and vascular complications, as only minimal hematomas (EASY Class I-II) and one case of artery perforation have been described. Finally, the retrograde reopening of the radial artery offers a long term patency result—after one, three, six and nine months from the intervention—in most of the investigated cohorts [32].
Nonetheless, these invasive management strategies to restore blood flow cannot be routinely utilized, and the use of this recanalized radial artery as a graft for coronary bypass surgery or for arteriovenous fistula formation could be a risky choice, as this subject is not sufficiently investigated.

References

  1. Garg, N.; Umamaheswar, K.L.; Kapoor, A.; Tewari, S.; Khanna, R.; Kumar, S.; Goel, P.K. Incidence and predictors of forearm hematoma during the transradial approach for percutaneous coronary interventions. Indian Heart J. 2019, 71, 136–142.
  2. Tsigkas, G.; Papageorgiou, A.; Moulias, A.; Kalogeropoulos, A.P.; Papageorgopoulou, C.; Apostolos, A.; Papanikolaou, A.; Vasilagkos, G.; Davlouros, P. Distal or Traditional Transradial Access Site for Coronary Procedures. JACC Cardiovasc. Interv. 2022, 15, 22–32.
  3. Pancholy, S.B.; Patel, V.; Pancholy, S.A.; Patel, A.T.; Patel, G.A.; Shah, S.C.; Patel, T.M. Comparison of Diagnostic Accuracy of Digital Plethysmography Versus Duplex Ultrasound in Detecting Radial Artery Occlusion After Transradial Access. Cardiovasc. Revasculariz. Med. 2021, 27, 52–56.
  4. Jirous, S.; Bernat, I.; Slezak, D.; Miklik, R.; Rokyta, R. Post-procedural radial artery occlusion and patency detection using duplex ultrasound vs. the reverse Barbeau test. Eur. Heart J. Suppl. 2020, 22, F23–F29.
  5. Alberti, M.; Bucca, G.; Somenzi, A.; Mellino, A.; Gamberini, S.; Daniele, B.; Giancola, F.; Bonomi, A.; Moro, M. . Assist Inferm Ric. 2021, 40, 213–220.
  6. Indolfi, C.; Passafaro, F.; Sorrentino, S.; Spaccarotella, C.; Mongiardo, A.; Torella, D.; Polimeni, A.; Sabatino, J.; Curcio, A.; De Rosa, S. Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. J. Clin. Med. 2018, 7, 319.
  7. Wang, H.; Yin, D.; Feng, L.; Song, W.; Wang, H.; Zhu, C.; Dou, K. Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients. Catheter. Cardiovasc. Interv. 2021, 97, 1063–1071.
  8. Buturak, A.; Gorgulu, S.; Norgaz, T.; Voyvoda, N.; Sahingoz, Y.; Degirmencioglu, A.; Dagdelen, S. The long-term incidence and predictors of radial artery occlusion following a transradial coronary procedure. Cardiol. J. 2014, 21, 350–356.
  9. Aykan, A.; Gökdeniz, T.; Gül, I.; Kalaycıoğlu, E.; Çetin, M.; Hatem, E.; Çavuşoğlu, I.G.; Karabay, C.Y.; Güler, A.; Aykan, D.A.; et al. Comparison of low dose versus standard dose heparin for radial approach in elective coronary angiography? Int. J. Cardiol. 2015, 187, 389–392.
  10. Munir, U.; Khan, R.; Nazeer, N.; Akhter, J.; Hassan, A.U.; Hanif, B. Frequency and Predictors of Radial Artery Occlusion in Patients Undergoing Percutaneous Coronary Intervention. Cureus 2022, 14, e25505.
  11. Nguyen, P.; Makris, A.; Hennessy, A.; Jayanti, S.; Wang, A.; Park, K.; Chen, V.; Nguyen, T.; Lo, S.; Xuan, W.; et al. Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): A randomised controlled trial. Eurointervention 2019, 15, e522–e530.
  12. Seto, A.H.; Roberts, J.S.; Abu-Fadel, M.S.; Czak, S.J.; Latif, F.; Jain, S.P.; Raza, J.A.; Mangla, A.; Panagopoulos, G.; Patel, P.M.; et al. Real-Time Ultrasound Guidance Facilitates Transradial Access. JACC Cardiovasc. Interv. 2015, 8, 283–291.
  13. da Silva, R.L.; de Andrade, P.B.; Dangas, G.; Joaquim, R.M.; da Silva, T.R.; Vieira, R.G.; Pereira, V.C.; Sousa, A.G.; Feres, F.; Costa, J.R. Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin. JACC Cardiovasc. Interv. 2022, 15, 1009–1018.
  14. Chen, Y.; Ke, Z.; Xiao, J.; Lin, M.; Huang, X.; Yan, C.; Ye, S.; Tan, X. Subcutaneous Injection of Nitroglycerin at the Radial Artery Puncture Site Reduces the Risk of Early Radial Artery Occlusion After Transradial Coronary Catheterization. Circ. Cardiovasc. Interv. 2018, 11, e006571.
  15. Beyer, A.T.; Ng, R.; Singh, A.; Zimmet, J.; Shunk, K.; Yeghiazarians, Y.; Ports, T.A.; Boyle, A.J. Topical nitroglycerin and lidocaine to dilate the radial artery prior to transradial cardiac catheterization: A randomized, placebo-controlled, double-blind clinical trial. Int. J. Cardiol. 2013, 168, 2575–2578.
  16. Ezhumalai, B.; Satheesh, S.; Jayaraman, B. Effects of subcutaneously infiltrated nitroglycerin on diameter, palpability, ease-of-puncture and pre-cannulation spasm of radial artery during transradial coronary angiography. Indian Heart J. 2014, 66, 593–597.
  17. Dharma, S.; Kedev, S.; Patel, T.; Sukmawan, R.; Gilchrist, I.C.; Rao, S.V. Post-procedural/pre-hemostasis intra-arterial nitroglycerin after transradial catheterization: A gender based analysis. Cardiovasc. Revasculariz. Med. 2016, 17, 10–14.
  18. Pancholy, S.B. Comparison of the Effect of Intra-Arterial Versus Intravenous Heparin on Radial Artery Occlusion After Transradial Catheterization. Am. J. Cardiol. 2009, 104, 1083–1085.
  19. Chiang, C.-Y.; Chang, W.-T.; Ho, C.-H.; Hong, C.-S.; Shih, J.-Y.; Wu, W.-S.; Chen, Z.-C.; Chou, M.-T. Radial artery occlusion with a kaolin-filled pad after transradial cardiac catheterization. Medicine 2018, 97, e13134.
  20. Due-Tønnessen, N.; Egeland, C.H.; Meyerdierks, O.J.; Opdahl, A. Is radial artery occlusion and local vascular complications following transradial coronary procedures affected by the type of haemostasis device used? A non-inferiority Randomized Controlled Trial (RadCom trial). Eur. J. Cardiovasc. Nurs. 2021, 20, 580–587.
  21. Sanghvi, K.A.; Montgomery, M.; Varghese, V. Effect of hemostatic device on radial artery occlusion: A randomized comparison of compression devices in the radial hemostasis study. Cardiovasc. Revasculariz. Med. 2018, 19, 934–938.
  22. Bernat, I.; Bertrand, O.F.; Rokyta, R.; Kacer, M.; Pesek, J.; Koza, J.; Smid, M.; Bruhova, H.; Sterbakova, G.; Stepankova, L.; et al. Efficacy and Safety of Transient Ulnar Artery Compression to Recanalize Acute Radial Artery Occlusion After Transradial Catheterization. Am. J. Cardiol. 2011, 107, 1698–1701.
  23. Balaban, Y.; Elevli, M.G. It is both possible and safe to perform coronary angiography through the same radial artery, after retrograde recanalization of radial artery occlusion, following a previous coronary angiography. J. Interv. Cardiol. 2018, 31, 957–963.
  24. Didagelos, M.; Pagiantza, A.; Zegkos, T.; Zarra, K.; Angelopoulos, V.; Kouparanis, A.; Peteinidou, E.; Kassimis, G.; Karvounis, H.; Ziakas, A. Low Molecular Weight Heparin in Improving RAO After Transradial Coronary Catheterization. JACC Cardiovasc. Interv. 2022, 15, 1686–1688.
  25. Didagelos, M.; Pagiantza, A.; Zegkos, T.; Papanastasiou, C.; Zarra, K.; Angelopoulos, V.; Kouparanis, A.; Peteinidou, E.; Sianos, G.; Karvounis, H.; et al. Low-molecular-weight heparin in radial artery occlusion treatment: The LOW-RAO randomized study. Futur. Cardiol. 2022, 18, 91–100.
  26. Steinmetz, M.; Radecke, T.; Boss, T.; Stumpf, M.J.; Lortz, J.; Nickenig, G.; Kania, A.; Rassaf, T.; Rammos, C.; Schaefer, C.A. Radial artery occlusion after cardiac catheterization and impact of medical treatment. Vasa 2020, 49, 463–466.
  27. Zankl, A.R.; Andrassy, M.; Volz, C.; Ivandic, B.; Krumsdorf, U.; Katus, H.A.; Blessing, E. Radial artery thrombosis following transradial coronary angiography: Incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin. Res. Cardiol. 2010, 99, 841–847.
  28. TCT-525: Impact of Low Molecular Weight Heparin on Reperfusion Rates in Patients with Radial Artery Occlusion after Cardiac Catheterization. Results and Follow-Up in 113 patients. J. Am. Coll. Cardiol. 2011, 58, B143.
  29. Roy, S.; Choxi, R.; Wasilewski, M.; Jovin, I.S. Novel oral anticoagulants in the treatment of radial artery occlusion. Catheter. Cardiovasc. Interv. 2021, 98, 1133–1137.
  30. Fu, Y.; Zuo, K.; Yang, Y.; Gao, Y.; Liu, L.; Ding, X.; Wang, L.; Xu, L. Distal Transradial Access: A Safe and Feasible Approach for Coronary Catheterization in Cases of Total Radial Artery Occlusion. J. Cardiovasc. Transl. Res. 2022, 15, 1203–1211.
  31. Lin, Y.; Bei, W.; Liu, H.; Liu, Q.; Yuan, J.; Wu, M.; Sun, X.; Dong, S. Retrograde recanalization of radial artery occlusion via the distal transradial artery: A single-center experience. Front. Cardiovasc. Med. 2022, 9, 985092.
  32. Achim, A.; Kákonyi, K.; Jambrik, Z.; Olajos, D.; Nemes, A.; Bertrand, O.F.; Ruzsa, Z. Distal Radial Artery Access for Recanalization of Radial Artery Occlusion and Repeat Intervention: A Single Center Experience. J. Clin. Med. 2022, 11, 6916.
More
Information
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , , , , , , , ,
View Times: 513
Revisions: 2 times (View History)
Update Date: 14 Jul 2023
1000/1000
Video Production Service